CST Guide:
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
14<br />
Section II: ANTIBODY APPLICATIONS<br />
Western Blotting (WB)<br />
Protein Detection<br />
Western blotting (WB) or immunoblotting is the most common technique used for monitoring protein<br />
expression in cells or tissue. WB can be used to measure total or modification-specific protein levels<br />
qualitatively or quantitatively by chemiluminescent or fluorescent detection. The WB protocol comprises<br />
multiple steps beginning with preparation of cell lysate and separation of cellular proteins by molecular<br />
weight on a polyacrylamide gel matrix (SDS-PAGE). The separated proteins are then transferred to a<br />
nitrocellulose or polyvinylidene fluoride (PVDF) membrane and detected using target-specific antibodies.<br />
Prior to detection, the membrane is incubated in a blocking solution to prevent nonspecific antibody<br />
binding. A wide variety of primary antibodies can be used to probe western blots including modificationspecific,<br />
motif-specific, or total protein antibodies. Proteins can be detected indirectly using an<br />
unconjugated primary antibody specific to the target of interest coupled with a secondary antibody<br />
conjugated to either an enzyme (horseradish peroxidase or HRP) for chemiluminescent detection or an<br />
infrared dye for fluorescent detection. Alternatively, primary antibodies directly conjugated to HRP can<br />
be used to detect proteins in a one-step protocol.<br />
The most common challenges presented by WB analysis are weak signal and high background.<br />
The tips below will help you address the most common factors responsible for these problems.<br />
WB Tips for Success<br />
Incubate with primary antibody overnight<br />
to improve antibody-target binding.<br />
Overnight incubation of membrane and primary antibody can greatly enhance signal simply by allowing<br />
more time for antibody-antigen binding. We have found that overnight incubation, with gentle agitation,<br />
at 4°C results in stronger antibody specific signal.<br />
Primary antibody incubation overnight at<br />
4°C yields significantly increased antibody<br />
binding compared to a 2 hr incubation.<br />
Phospho-Akt (Ser473) Antibody #9271: WB analysis of extracts from HeLa<br />
cells, untreated or treated with LY294002 #9901 or Human Insulin-like Growth<br />
Factor I (hIGF-I) #8917, using #9271 (top) or PKC Antibody #2058 (bottom).<br />
kDa<br />
140<br />
100<br />
80<br />
60<br />
50<br />
40<br />
140<br />
100<br />
80<br />
60<br />
50<br />
40<br />
16 hr, 4°C<br />
2 hr, RT<br />
Phospho-<br />
Akt (Ser473)<br />
PKCδ<br />
- - +<br />
- - + LY294002<br />
- + + - + + hIGF-I<br />
Dilute secondary antibody in stronger<br />
blocking agents to reduce nonspecific signal.<br />
We suggest diluting secondary antibody in 5% nonfat milk in TBST rather than in 5% BSA in TBST. Milk<br />
offers stronger blocking of nonspecific binding, hence the BSA-based dilution yields significantly higher<br />
background than the milk-based dilution.<br />
Diluting secondary antibody in milk yields<br />
lower background levels because milk is a<br />
stronger blocking agent.<br />
Phospho-Stat3 (Tyr705) Antibody #9131: WB analysis of extracts from Jurkat<br />
cells, untreated or treated with Human Interferon-α1 (hIFN-α1) #8927, using #9131.<br />
Blots were incubated in Anti-rabbit IgG, HRP-linked Antibody #7074 diluted in either<br />
5% nonfat milk in TBST or 5% BSA in TBST, as indicated.<br />
kDa<br />
200<br />
140<br />
100<br />
80<br />
60<br />
50<br />
40<br />
Milk<br />
BSA<br />
– + – +<br />
Weak signal of mid-to-high molecular weight proteins.<br />
chapter 14: Western Blotting (WB)<br />
Phospho-<br />
Stat3<br />
Due to their large size, high molecular weight proteins do not typically transfer as efficiently as smaller<br />
proteins. Wet transfer often provides better transfer of mid-to-high molecular weight proteins than<br />
semi-dry or dry transfer methods. Additionally, because methanol acts as a fixative, decreasing the<br />
methanol concentration in transfer buffer from 20% to 5% and increasing transfer time to 3 hours can<br />
also improve transfer efficiency of proteins >200 kDa.<br />
Wet transfer provides better capture of mid-to-high<br />
molecular weight proteins and a stronger WB signal.<br />
Phospho-Stat3 (Tyr705) (D3A7)<br />
XP ® Rabbit mAb #9145: WB<br />
analysis of extracts from HeLa<br />
cells, untreated or treated with<br />
Human Interferon-α1 (hIFN-α1)<br />
#8927, using #9145 or a<br />
phospho-Stat3 (Tyr705) antibody<br />
from a competitor. Blots were<br />
transferred using either traditional<br />
wet transfer methods (left) or<br />
iBlot ® dry transfer system (right).<br />
kDa<br />
200<br />
140<br />
100<br />
80<br />
60<br />
50<br />
40<br />
30<br />
HeLa<br />
Wet Transfer<br />
Dry Transfer<br />
HeLa HeLa HeLa<br />
hIFN-α1<br />
Phospho-<br />
Stat3 (Tyr705)<br />
Sonicate lysates to increase nuclear protein recovery.<br />
20<br />
kDa<br />
100<br />
80<br />
Sonication thoroughly disrupts both cell and nuclear membranes, improving cell lysis and resulting in<br />
higher protein levels in clarified lysate. This enhanced membrane disruption is especially important<br />
for nuclear proteins, which may not be completely released through detergent use alone. If you do not<br />
have access to a probe sonicator, passing samples through a fine gauge needle will also serve to break<br />
membranes and shear DNA.<br />
– +<br />
<strong>CST</strong> #9145<br />
– + – + – +<br />
Alternate<br />
Provider<br />
<strong>CST</strong> #9145<br />
Alternate<br />
Provider<br />
hIFN-α1<br />
60<br />
50<br />
40<br />
30<br />
Lysate sonication is critical to the observation<br />
of nuclear and chromatin-bound proteins.<br />
20<br />
10<br />
-<br />
Sonicated<br />
+ - + sorbitol<br />
Unsonicated<br />
Phospho-<br />
Histone H3<br />
(Ser10)<br />
Phospho-Histone H3 (Ser10) Antibody #9701: WB analysis of extracts from CKR/PAEC cells,<br />
untreated or treated with sorbitol and either sonicated or without sonication, using #9701.<br />
WB Protocols and Troubleshooting Videos<br />
For more in-depth help with WB, please see our online WB Protocols and Troubleshooting videos.<br />
www.cellsignal.com/wbvideo<br />
226 For Research Use Only. Not For Use in Diagnostic Procedures. See pages 302 & 303 for Pathway Diagrams, Application, and Reactivity keys.<br />
www.cellsignal.com/cstwb<br />
227